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1. Introduction 
Oxidative stress (OS) represents a loss of balance in oxidation-reduction reactions (redox 
state). It is characterized by the reduced ability of the antioxidant defense system to 
efficiently eliminate the excess of the oxygen-derived species production, eliciting the 
toxicity of oxygen and its detrimental effects. 
OS state is related to probably more than 100 human diseases including male infertility, 
autoimmune diseases, atherosclerosis, cardiovascular troubles, diabetes and cancer. 
Interestingly, certain diseases associated with OS disturbances such as neurodegenerative 
diseases and neuropsychiatric diseases including schizophrenia and some forms of 
behaviour, such as aggressiveness, depression and anxiety are more specific for the nervous 
system impairments. In particular, recent research observed a close relationship between OS 
and anxiety in both human patients suffering from anxiety disorder (obsessive–compulsive 
disorder and panic disorder), and humans and animals displaying high trait anxiety 
(Bouayed & Bohn, 2010; Bouayed, 2010; Bouayed et al., 2009). It has been debated that brain 
OS disturbances might be a plausible pathogenesis and risk factor for several specific 
diseases of the nervous system including behavioural troubles and disorders (Ng et al., 2008; 
Bouayed, 2010; Bouayed et al., 2009).  
Brain controls several activities and functions including emotion; a correct function of the 
nervous system, that is mediated by neurotransmitters and its adequate interaction with 
other regulatory systems including the endocrine system (involving hormones) and the 
immune system (involving cytokines) is crucial for health. Oxygen is very essential for brain 
activity and in this respect mammal brain is highly sensitive to oxygen deprivation and even 
short duration of hypoxia can cause irreversible damage or even death. Albeit oxygen is 
vital, high oxygen-derived species production (through respiration and metabolism) 
produces toxicity in brain, owing to its intrinsic oxidative vulnerability (Mariani et al., 2005; 
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Halliwell, 2006; Ng et al., 2008; Bouayed et al., 2009). Interestingly, human brain uses about 
20% of oxygen consumed by the body even though this organ constitutes only about 2% of 
the body weight (Halliwell, 2006; Bouayed et al., 2009).  The high energy needed by the 
brain may explain its high oxygen uptake. However, the antioxidative defense system of the 
brain is not well equipped (due to relatively low levels of certain antioxidant enzymes, 
particularly catalase) to deal with the high rate of reactive oxygen species (ROS) resulting 
from the brain’s high oxygen consumption (Mariani et al., 2005; Halliwell, 2006). Catalase 
and glutathione peroxidase play a key role in the catabolism of hydrogen peroxide (H2O2) 
into water and oxygen, avoiding the formation of the highly reactive hydroxyl radicals 
(OH•) following the Fenton reaction  
(H2O2 + Fe 2+ or (Cu+)  •OH + –OH + Fe 3+ or (Cu2+)) or  
Haber–Weiss reaction (O2•– + H2O2  •OH + –OH + O2) (Valko et al., 2007). 
Brain metabolism produces a lot of H2O2, while low levels of catalase have been reported in 
the most brain regions (Halliwell, 2006). In addition, the abundant presence of iron and 
copper ions in neuronal cells (Hovatta et al., 2010) may catalyze the production of OH• and 
RO• generated via peroxides (H2O2 and ROOH, respectively). Neuronal membrane lipids, 
which are rich in highly polyunsaturated fatty acids, may undergo rapid lipid peroxidation 
following the occurrence of OS (Mariani et al., 2005; Halliwell, 2006; Bouayed et al., 2009). 
The sensitivity of brain to oxygen increases with increasing age following the natural 
consequence of brain aging, which is characterized among others by the declining ability of 
the antioxidant system to prevent against oxidative damages resulting from non-detoxified 
ROS (Mariani et al., 2005; Pandey & Rizvi, 2010).  
The present chapter focuses on the link between OS and anxiety, discussing and reviewing 
different findings obtained from humans and rodents in this field. The emerging role of 
antioxidants as a potential new strategy for the prevention and treatment of anxiety is also 
debated. 
2. Anxiety disorder and OS 
GABAergic and serotoninergic systems are considered among the principal regulatory 
systems of anxiety. However, following to recent findings of Kuloglu et al. (2002a and 
2002b)— emphasizing that patients with anxiety disorders (obsessive–compulsive disorder 
and panic disorder), compared to healthy controls, have higher activity levels of the 
antioxidant enzymes superoxide dismutase and glutathione peroxidase as well as higher 
lipid peroxidation activity — oxidative metabolism is being also regarded as a plausible 
pathway that can affect the regulation of anxiety. This hypothesis has gained interest due to 
the intrinsic oxidative vulnerability of the brain (see above). When the production of ROS 
prevails over the brain defense systems, the lipid-rich constitution of brain may favour lipid 
peroxidation, constituting a free radical chain reaction that may result in decrease in 
membrane fluidity and damage in membrane proteins inactivating receptors, enzymes and 
ion channels, even disrupting membrane integrity resulting eventually in cell death. In 
addition to oxidative damage of neuronal membrane lipids and proteins, oxidation of other 
sensitive components such as nucleic acids and neurotransmitters can occur. As a result, OS 
can alter neurotransmission, neuronal function and overall brain activity (Bouayed et al., 
2009). Therefore, brain oxidative damage might be also a plausible pathogenic factor for 
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certain multifactorial neurological diseases including neuropsychiatric troubles. 
Interestingly, OS state was recently linked to other behavioural disorders, such as aggressive 
behaviour and depression, and also to deterioration of short-term spatial memory (Bouayed et 
al., 2009, 2010; Dean et al., 2009; Bouayed, 2010), highlighting that OS disturbances could be 
implicated in the pathophysiology of conditions that are more specific for the nervous system 
impairment. In this respect, we have reported a statistically significant positive correlation 
between aggressive behaviour in the resident/intruder test and cell oxidative status in adult 
male mice (Rammal et al., 2010b). Moreover, patients suffering from major depression have 
presented OS in both their peripheral as well as their central systems (Bilici et al., 2001, Michel 
et al., 2007). Curiously, some of these conditions (e.g. aggressiveness and depressed mood) 
could also be associated with anxiety. For instance, Bayani et al. (2007) demonstrated that in 
teachers, the high level of anxiety is associated with a high level of hostility. In animals, it has 
been shown that dominant rodents had high levels of anxiety and they often exhibited 
aggressive behaviour toward subaltern subjects (Ferrari et al., 1998; Blanchard et al., 1993).  
Anxiety may also coexist with depression and for defining these states the term comorbidity 
is usually used. Such mixed states of anxiety and depression make coping of the disease 
more difficult. It concerns both general prognosis, as well as treatment response in this 
cohort of patients. For example, in the Finnish population-wide Health 2000 Survey, it has 
been estimated that 35.9% of the anxiety disorder patients had a comorbid depressive 
disorder (major depressive disorder and/or dysthymia) (Pirkola et al., 2005). 
In their studies, Kuloglu et al. (2002a and 2002b) have used the activity of antioxidant 
enzymes (e.g. superoxide dismutase and glutathione peroxidase) in erythrocytes and the 
level of malondialdehyde in plasma as markers of oxidative status of human subjects 
(healthy volunteers versus patients suffering from obsessive–compulsive disorder and panic 
disorder). Other human studies have shown the validity of these biomarkers to assess OS 
state. For example, several studies have demonstrated that peripheral oxidative status 
markers in human erythrocytes and plasma significantly correlated with human age, and as 
a result they have been proposed as biomarkers of the aging process, which is characterized 
by an increase of oxidative stress with age (Pandey & Rizvi, 2010).  
3. High anxiety level and OS 
In the light of results from Kuloglu et al (2002a and 2002b) establishing a relationship 
between OS and anxiety disorder, other recent studies have focused on the link between 
redox status and normal anxiety, and also on a possible causal relationship between cellular 
oxidative stress and emotional stress using rodents as animal model. Mice and rats are often 
used as translational models for studying anxiety in humans due to the similarity in the 
extremely complex mechanisms involved in anxiety in these species. Indeed, the principal 
brain areas (e.g. the amygdala) implicated in the processing (or the suppression) of fear and 
anxiety, the comparable brain circuits involved with anxiety, and the similar neurochemical 
substrates (e.g. GABA, serotonin) among others, make rodents a good model to study 
anxiety in humans (Mathew et al., 2008). Anxiety of rodents is detected from specific 
behavioural model tests, among which the elevated plus maze, the light/dark choice test, 
open field test and hold board test are most employed. These behavioural tests are also 
sensitive to pharmacological agents with anxiolytic or anxiogenic properties, causing a 
decrease or an increase in the anxiety-related behaviour of animals, respectively.  
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Based on their anxiety-like behaviour assessed in both the dark/light choice test and the 
open field test, Hovatta et al., (2005) ranked six inbred mouse strains from the less anxious 
to the more anxious. Afterwards, they have demonstrated a close correlation between brain 
expression of genes of the antioxidative defense system (glutathione reductase 1 and glyoxalase 
1) and anxiety-related phenotypes across all mouse strains. They further found that the 
activity of the antioxidative enzymes of glutathione reductase 1 and glyoxalase 1 is highest 
in the most anxious strain and lowest in the least anxious strains. A link between OS and 
emotional stress is not surprising per se; since it is well accepted that oxidative damage in 
the brain may cause an impairment of the nervous system. For example, abnormalities in the 
regulatory systems of anxiety in rodents (e.g. GABAergic and serotoninergic systems) can 
result in anxious behaviour. Furthermore, alteration of the function of the hypothalamic-
pituitary-adrenal (HPA) axis, which is implicated in stress responses and anxiety disorders, 
could also impact the emotional response. However, the second part of results of Hovatta et 
al. (2005) obtained from a genetic manipulation using lentivirus-mediated gene transfer was 
surprising because the role of oxidation or reactive oxygen species is not clear in the genesis 
of anxiety, despite the role of glyoxalase 1 and glutathione reductase 1 in the regulation of 
anxiety in transgenic mice was established. Indeed, they found that local overexpression of 
glutathione reductase 1 and glyoxalase 1 in the cingulated cortex of the murine brain results in 
an increase of anxiety-like behaviour, while inhibition of glyoxalase 1 expression produces 
low-anxiety. Thus, Hovatta et al. (2005) were able to make a causal link between the 
antioxidative status of the brain and anxiety-related behaviour supposing that glyoxalase 1 
and glutathione reductase 1 regulate anxiety in mice. However, in vivo, antioxidant genes (e.g. 
superoxide dismutase, glutathione peroxidase and glutathione reductase) are normally 
overexpressed in response to an uncontrolled production of ROS. In certain cases, OS leads 
to silencing of genes encoding antioxidant defensive enzymes. In the lentivirus experiments 
of Hovatta et al., (2005) however, the overexpression of the transgenes (glyoxalase 1 and 
glutathione reductase 1) was induced in vivo with a lentiviral vector and not an excessive 
production of toxic oxygen metabolites. Clearly, the mechanism by which these antioxidant 
defensive enzymes regulate anxiety is of great interest. Additionally, Hovatta et al., (2005) 
used glyoxalase 1, which is an enzyme of the glyoxalase system, as a marker of oxidative 
stress, however the link is indirect. Enzymatic activity of glyoxalase 1 aims to protect against 
carbonyl stress (resulting from excessive accumulation of reactive dicarbonyl compounds). 
Carbonyl stress leads to protein and nucleotide damages by dicarbonyl glycation, which is 
associated with several pathologies including diabetes (Thornalley, 2006a, 2006b and 2006c). 
Glutathione (GSH), which is a major antioxidant in the brain, constitutes a determinant 
cofactor for the enzymatic reaction that is catalyzed by glyoxalase 1. However, a close 
relation between oxidative stress and carbonyl stress was established. 
Curiously, other findings from another laboratory (Krömer et al., 2005; Ditzen et al., 2006) 
have complicated the understanding the role of glyoxalase 1 in trait anxiety because they are 
discordant with those of Hovatta et al. (2005). Contradictory, they have proposed that the 
level of expression of glyoxalase 1 could be used as a physiological marker of trait anxiety 
level, with high protein expression indicating low trait anxiety level and low expression for 
high trait anxiety. Indeed, comparing two Swiss CD1 mouse lines with extremes in trait 
anxiety, these authors found that glyoxalase 1 was more expressed in the line with low-
anxiety-related behavioural phenotype than in the line with high-anxiety-related 
behavioural phenotype. The expression of glyoxalase 1 has been assessed in several brain areas 
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and also in red blood cells of mice. The lines of mice with contrasting anxiety-like behavioural 
phenotypes were generated from wild type mice after > 15 generations of selection. 
Differences in the genotype of this strain and those used by Hovatta et al. (2005) could play a 
role in the differences of observed results. Thus, it would be interesting to compare in the same 
strain, anxiety-related behaviour of mice with their oxidative status rather than compare the 
redox status of strains differing in their anxiety-related phenotypes. This approach takes into 
account the intra-variability between individuals of the same strain. 
Because of the large heterogeneity in their anxiety levels, Swiss albino male mice (OF1) 
constitute an interesting behavioural model to study the link between oxidative status and 
anxiety-related behaviour. Correlation analyses indicated a linear and significant 
relationship between the intracellular redox status of peripheral blood granulocytes and 
different parameters of anxiety-related behaviour, assessed in the behavioural light/dark 
choice test, including latency time (R2=0.74, P<0.001), cumulative time spent in the lit box 
(R2=0.61, P<0.01) and number of entries into the lit box (R2=0.66, P<0.01) (Bouayed et al., 
2007, 2009). Our results suggested a positive relationship between peripheral oxidative 
status and level of anxiety in mice. To confirm the relationship between OS and emotional 
stress, we comparatively evaluated the peripheral oxidative status of mice with contrasting 
levels of anxiety (anxious and non-anxious). Following strict selection criteria from a general 
population of 100 mice (Rammal et al., 2008a, 2008b, 2010), only 10% of mice were 
considered as anxious (n = 10) and 10% as non-anxious (n = 10). Thus, mice with 
intermediate behaviours were eliminated (n=80). We found that high anxiety level was 
associated with a significant generation of ROS in the peripheral blood lymphocytes, 
granulocytes and monocytes in mice compared to low anxiety level (Rammal et al., 2008a). 
Our results confirm that there is a relationship between the level of intracellular ROS in 
peripheral blood cells and anxiety-related behaviour in mice. These results prompted us to 
study the oxidative status of the brain in mice with distinct levels of anxiety. Using the same 
behavioural approach to distinguish between anxious and non-anxious mice, we found that 
anxiety levels were associated with the oxidative status in both neuronal and glial cells in 
the cerebellum and hippocampus, in neurons of the cerebral cortex and in peripheral 
leucocytes (monocytes, granulocytes and lymphocytes) (Rammal et al., 2008b). Our results 
clearly indicated the presence of OS in the central and peripheral systems of anxious mice. 
OS in the brain and blood immune cells could predispose anxious mice to 
neuroinflammation and neurodegeneration as well as recurrent infections. In another study, 
we have found that high levels of anxiety inhibited part of the cellular and humoral immune 
systems by significantly decreasing total lymphocytes numbers (including TCD4+ and 
TCD8+) and immunoglobulin (A and E) concentrations, emphasising the vulnerability of 
anxious mice to infections (Rammal et al., 2010a). We considered that type of anxiety 
evaluated in mice with contrasting levels of anxiety is a trait-anxiety, for two reasons. First, 
we have verified that the level of anxiety of anxious and non-anxious mice was stable 
during time (a period of 15 days). In fact, they did not change their status of anxiety in the 
light/dark choice test. Secondly, we have also verified that in a general population of mice, 
the anxious (or non-anxious) mice in the light/dark choice test are usually the anxious (or non-
anxious) in the elevated plus maze. We have also found that the general activity, both 
horizontal (locomotion) and vertical (rears), of anxious mice was significantly lower than of 
non-anxious mice (unpublished results), which was in keeping with the findings of do-Rego et 
al. (2007) comparing anxious with non anxious male Swiss albinos CD1 mice. These authors 
also found that these groups of mice did not significantly differ with regard to their immobility 
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time, marker of depressive behaviour, in the forced swimming test. In agreement with these 
results, we have also found that the behaviour of anxious and non-anxious mice did not 
significantly vary in the tail suspension and forced swimming tests, the well-known predictive 
tests of depression-related behaviour (unpublished results). From the above, it could be 
suggested that high trait anxiety level in anxious mice from Swiss albino male mice (OF1) was 
not associated with depressive symptoms.  
The results of our studies are in good concordance with the initial findings of Hovatta et al. 
(2005) associating OS to high trait anxiety level, but our findings do not permit us to declare 
a causal relationship between these stresses. In keeping with the animal experiments, the 
link between OS and human trait anxiety was also determined. Indeed, Yasunari et al. (2006) 
found a significant relationship between trait anxiety and ROS formation in monocytes of 
hypertensive individuals. 
To study the causal relation between OS and anxiety, Masood et al. (2008) provoked OS by 
depleting glutathione (GSH) in mice using buthionine-S,R-sulfoximine (BSO), and 
afterwards they assessed the impact of BSO treatment on the level of anxiety. Surprisingly, 
BSO-treated mice developed anxious behaviour in several mouse models of anxiety 
including elevated plus maze, hole-board and open field tests. The NADPH oxidase was 
suggested to be the principal oxidative pathway responsible for the anxiogenic behaviour 
following BSO treatment. Depletion of GSH was also reported to cause cognitive 
impairment (short-term spatial memory disturbances) in rodents as assessed in the Y-maze 
test (Dean et al., 2009). It is also suggested that GSH might play a role in psychiatric illnesses 
including schizophrenia and bipolar disorder (Dean et al., 2009). However, despite that GSH 
is considered as a major antioxidant in aerobic cells functioning as an important cellular 
redox buffer, GSH depletion can cause other cellular stresses, including nitrosative and 
carbonyl stresses, as GSH is also an important determinant of the nitrogen and dicarbonyl 
metabolism. Excessive production of ROS induces oxidative damage of cellular structures; 
production of reactive nitrogen species triggers nitrosylation reactions, which can alter the 
structure of proteins to inhibit their normal function; excessive accumulation of reactive 
dicarbonyl compounds leads to damage of protein and nucleotides by dicarbonyl glycation. 
Additionally, GSH may also have an additional double role in the central nervous system by 
acting as a neurotransmitter and neuromodulator, e.g. by regulating the release of other 
neurotransmitters such as dopamine and gamma-aminobutyric acid (GABA), which is an 
important regulator of anxiety (Oja et al., 2000). Therefore, the anxiogenic behaviour 
resulting from depletion of GSH in mice could be independent from oxidative metabolism 
disturbances generated by BSO treatment. Thus, it is difficult to deduce, from this study, a 
direct causal relationship between oxidative stress and anxiety.  
Other studies have mentioned that OS state could cause anxiogenic behaviour, however the 
link is indirect. Desrumaux et al. (2005) showed that vitamin E deficiency in the mouse brain 
significantly causes brain OS, resulting in anxiogenic behaviour without abnormalities in the 
locomotor performance of the mice. Souza et al. (2007) demonstrated in rats that the 
consumption of a highly palatable diet enriched with sucrose leads to an obese phenotype, 
increases protein oxidation in the frontal cortex and induces anxiety-like behaviour in the 
dark/light choice test without altering locomotion in an open field test. Berry et al. (2007) 
showed that mice developed anxious behaviour during aging, likely due to the accumulation 
of oxidative damage, which is a characteristic of the aging process in animals. In addition, 
Berry et al. (2007) showed that a deletion of the p66Shc longevity gene in mice, which results in 
lower levels of OS and an extended life span, decreased anxiety-related behaviour.  
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4. Antioxidants as therapeutic or preventive approaches 
At physiologic conditions, antioxidants play a crucial role in maintaining redox homeostasis 
by maintaining the level of ROS at physiological doses necessary for optimal cellular 
functioning. Thus, the excess of ROS is neutralized by antioxidants avoiding the oxidation of 
cellular components and consequently their damage. Exogenous antioxidants complete the 
antioxidative action of endogenous antioxidants by acting together, e.g. additively or 
synergistically. The principal source of exogenous antioxidants is our diet. However, diets 
relatively deficient in antioxidants may favour oxidative stress. Vitamin E, vitamin C, 
carotenoids, zinc, selenium, and polyphenols (e.g. phenolic acids and flavonoids) constitute 
the principal dietary antioxidants existing in food. Of course, these antioxidants can be 
found naturally (e.g. in plant foods or animal products such as eggs and honey), however, 
other sources can also exist (e.g. supplementation and fortification). Currently, there is 
increasing evidence that the advantageous effects of antioxidants on health are not only 
attributed to their antioxidant properties. This is due to the fact that antioxidants can also act 
e.g. as signalling molecules or as chemopreventive agents by displaying other activities such 
as anti-inflammatory activity (Bouayed & Bohn, 2010). The effect of dietary antioxidants on 
the central nervous system has gained interest in the last decades. In this sense, it has been 
demonstrated that dietary antioxidants can also exhibit cognitive enhancing effect, 
psychostimulant activity, and antidepressant and anti-anxiety properties. For example, it 
has been shown that antioxidants (e.g. vitamin C, rutin, caffeic acid and rosmarinic acid) 
possess antidepressant activity with relatively lower doses (0.1-2 mg/kg) than commonly 
used antidepressants such as imipramine or fluoxetine, which are active at higher doses (≥ 
10 mg/kg) in rodents. The mechanism of action of antioxidants on the central nervous 
system is not well elucidated, however, it has been demonstrated that rutin exerts its 
antidepressant activity similarly to conventional antidepressants by increasing the 
availability of serotonin and noradrenalin in the synaptic cleft (reviewed by Bouayed , 2010). 
Interestingly, antioxidant effects of conventional antidepressants have been reported in 
several studies (Atmaca et al., 2004; Réus et al., 2010). The antioxidant effects of anxiolytic 
treatments with citalopram (also used as an antidepressant) have been emphasized by 
Atmaca et al. (2004) on patients with social phobia. Polyphenols have also shown their 
ability to reverse anxiety-related behaviour of rodents. Some polyphenols have a 
pharmacological profile that suggests a partial agonistic action that may produce the 
anxiolytic-like effects, but without the side effects such as dependency, which are a feature 
of full agonists such as benzodiazepines. For example, at 3 mg/kg, apigenin exerts its 
anxiolytic effect in mice without sedation or myorelaxant effects. However, a 10-fold 
increase in dosage of this flavonoid produced slight sedative effects. Polyphenols may 
present a dose-effect response on the central nervous system. Rosmarinic acid at a dose of 2-
4 mg/kg exhibited anti-anxiety effects, however, in the same animal model this polyphenol 
exerted psychostimulant effects at the dose 8 mg/kg. Contrarily to conventional anxiolytics, 
which only have anti-anxiety effects at relatively low doses (1-5 mg/kg), polyphenols can 
display anxiolytic effects at a spectrum of doses ranging from 2 to 30mg/kg. For example, 
chlorogenic acid and (−)-epigallocatechinn gallate (EGCG) are active at 25 mg/kg and 30 
mg/kg, respectively. The ability of polyphenols to cross the blood-brain barrier might 
explain the difference in their active concentration. The intranasal administration of 
polyphenols in the form of liposomes could be an effective strategy both to facilitate the 
movement of these substances across the blood-brain barrier and to effectively reduce the 
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active dose. For example, it has been shown that quercetin, which is a flavonoid having 
difficulty crossing the blood-brain barrier, that its single intrasanal administration (20 μg) to 
rats reduced the active oral dose (300 mg/kg) by around 6000 times. Noteworthy, the 
reduction of anxiety was obtained by the oral administration of quercetin (300 mg/kg) but 
only after one-week of daily treatment. Therefore, the use of liposomes is a potentially novel 
strategy which can facilitate the delivery of polyphenols across the blood-brain barrier and 
also can effectively reduce the active dose (reviewed by Bouayed, 2010).  
Although psychopharmacological studies present antioxidants as a potential new strategy 
for the treatment of anxiety and depression, the use of these substances has to be with 
caution. Several studies are required to investigate the toxicity of antioxidants at non-
nutritional doses. At high doses, it has been discussed that antioxidants could enact 
deleterious effects on health, acting e.g. as prooxidants. As an example, it has been 
demonstrated that EGCG at pharmacological doses (30 and 60 mg/kg) abolishes anxiety in 
mice; at 150 mg/kg however this tea polyphenol caused death to mice (100% mortality) in 
less than 24 h, presumably due to its high hepatotoxicity noticed above 100 mg/kg. Despite 
that antioxidants, once outside in their natural matrix or at higher doses could be toxic, they, 
generally, are safe in plant foods due to their presence at physiological doses and also to 
their resulting combined effect (reviewed by Bouayed & Bohn, 2010). Therefore, 
antioxidants from a normal diet could prevent from anxiety development. In this respect, it 
has been demonstrated that some specific foods prevent aging-accompanying anxiety. 
Viggiano et al. (2006) demonstrated that anxiety of aged rats fed for 10 weeks with a 
standard diet supplemented with fresh apple fruits was significantly lower than aged rats 
fed with the standard diet. The decrease of anxiety was not associated with a change in 
general activity, however a reduction of OS was also found. Indeed, these authors found 
that brain superoxide dismutase (SOD) activity of aged rats fed with an apples enriched diet 
was not different from young animals feed with the standard diet with or without apples, 
while SOD activity of aged rats fed with the standard diet was significantly elevated. Pitozzi 
et al. (2010) found that aged rats fed, for one year, with a diet containing olive oil naturally 
rich in antioxidants have displayed a low anxiety than aged rats fed either with a diet 
containing olive oil naturally low in antioxidants or with maize oil. Interestingly, the 
reduction of anxiety was associated with significant decreased glutathione reductase activity 
and expression in the brain. Chepulis et al. (2009) conducted a study on rats fed ad libitum 
for 52 weeks with a diet that was either sugar-free or contained 7.9% sucrose or 10% honey 
(which is the equivalent amount of sugar). They found that anxiety of rats fed with the diet 
supplemented with honey was significantly lower than in the other groups. No information 
was given on the oxidative status of different groups; however, the antioxidant power of 
honey has already been stressed in other reports. It has been suggested that the anti-anxiety 
effect of long intake of apples, olive oil and honey may be attributed to the whole food 
matrix containing complex mixtures of nutrients and non-nutrients including vitamins, 
flavonoids, phenolic acids, several carotenoids, and many more acting on a synergistic or 
additive manner, rather than to specific compounds. 
5. Conclusion 
Anxiety has a multifactorial origin and can result e.g. from pharmacological treatment with 
some drugs (e.g. methyl-β-carboline-3-carboxylate), stressful situations (e.g. immobilization 
stress) or natural conditions (e.g. aging process). Although the link between OS disturbances 
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and anxiety is not disputed, whether oxidative stress is a side effect resulting from 
emotional stress, or inversely itself is the pathogenesis factor for this condition remains 
unclear. Nevertheless, results of Masood et al. (2008) showing that the well known 
anxiolytic diazepam does not fully reverse the anxiety generated by BSO treatment, can 
suggest that OS could be one of factors causing anxiety. Nevertheless, diazepam can abolish 
e.g. restraint stress-induced anxiety, although immobilization stress being a prooxidant. 
Interestingly, Masood et al. (2008) showed that OS-related anxiety could be reversed in mice 
after inhibition of NADPH oxidase or phosphodiesterase-2, enzyme that is indirectly 
implicated in OS mechanisms. Salim et al. (2010) demonstrated that anxiety generated by 
BSO treatment of rats was reversed either by preventive treatment by antioxidant using 
tempol, or by moderate treadmill exercise. It has been discussed that moderate physic 
activity reduces the vulnerability of brain to oxidative stress by increasing the resistance of 
brain antioxidant system following an adaptation, while acute or intense exercise are 
prooxidants. The vulnerability of brain to oxidative damages is in line with the theory that 
anxiety could be generated directly by OS. Antioxidants may constitute a potential 
treatment when OS is the causal factor in anxiety. In addition, a mixture of antioxidants and 
anxiolytics could be also a useful treatment in patients with anxiety, since OS is associated 
with anxiety disorders. It has been demonstrated that vitamin C caused a synergistic 
antidepressant-like effect with conventional antidepressants administered at subeffective 
doses. However, the use of antioxidants as a pharmacological approach to treat anxiety or as 
a co-adjuvant treatment with conventional anxiolytics should be employed with precaution. 
Indeed, antioxidants at high doses could become toxic by behaving e.g. as prooxidants. In 
this sense, supplementation of the human diet with high doses of antioxidants, e.g. vitamin 
C or carotenoids resulted in several adverse effects (reviewed by Bouayed & Bohn, 2010). 
Therefore, several studies are necessary to determine the safety of antioxidants at high 
doses, and the duration of the treatment, when the pharmacological approach is envisaged. 
However, antioxidants from natural foods rich in antioxidants could constitute a preventive 
therapy against anxiety, owing to their presence at physiological doses. Several animal 
studies have shown that long-term consumption of honey, apple or olive oil can prevent 
aging-accompanying anxiety. Nevertheless, the efficiency of antioxidants from fruits and 
vegetables has been prospectively verified against human diseases related to oxidative 
stress including coronary heart disease and stroke but has shown to be effective in 
preventing diseases predominantly when consumed at least at 5 portions per day.    
6. References 
Atmaca, M. Tezcan, E. Kuloglu, M. Ustundag, B. Tunckol, H. (2004). Antioxidant enzyme 
and malondialdehyde values in social phobia before and after citalopram 
treatment. Eur Arch Psychiatry Clin Neurosci, 245, 231-235. 
Bayani, A.A. Kocheki, A.M. (2007). Relationship between anxiety and hostility among 
teachers. European Psychiat, S268. 
Berry, A. Capone, F. Giorgio, M. Pelicci, P.G. de Kloet, E.R. Alleva, E. Minghetti, L. Cirulli, F. 
(2007). Deletion of the life span determinant p66Shc prevents age-dependent 
increases in emotionality and pain sensitivity in mice. Experimental Gerontology, 
42:37-45. 
www.intechopen.com
 
Anxiety Disorders 
 
36
Bilici, M. Efe, H. Koroglu, M.A. Uydu, H.A. Bekaroglu, M. Deger, O. (2001). Antioxidative 
enzyme activities and lipid peroxidation in major depression: alterations by 
antidepressant treatments. J Affect Disord, 64, 43-51. 
Blanchard, D.C. Sakai, R.R. McEwen, B. Weiss, S.M. Blanchard, R.J. (1993). Subordination 
stress: Behavioral, brain, and neuroendocrine correlates. Behav Brain Res, 58, 113–121. 
Bouayed, J, Rammal, H. Soulimani, R. (2009). Oxidative stress and anxiety: Relationship and 
cellular pathways. Oxid Med Cell Longev, 2(2), 63–67. 
Bouayed, J. (2010). Polyphenols: a potential new strategy for the prevention and treatment of 
anxiety and depression. Curr Nutr Food Sci, 6, 13-18. 
Bouayed, J. Bohn, T. (2010). Exogenous antioxidants - Double-edged swords in cellular 
redox state: Health beneficial effects at physiologic doses versus deleterious effects 
at high doses. Oxid Med Cell Longev, 3(4) 228–237. 
Bouayed, J. Rammal, H. Younos, C. Soulimani, R. (2007). Positive correlation between 
peripheral blood granulocyte oxidative status and level of anxiety in mice. Eur J 
Pharmacol, 564(1-3), 146-149. 
Chepulis, L.M. Starkey, N.J. Waas, J.R. Molan, P.C. (2009). The effects of long-term honey, 
sucrose or sugar-free diets on memory and anxiety in rats. Physiol Behav, 97(3-4), 
359-368. 
Dean, O. Bush, A. I. Berk, M. Copolov, D.L. van den Buuse, M. (2009). Glutathione depletion 
in the brain disrupts short-term spatial memory in the Y-maze in rats and mice. 
Behav Brain Res, 198, 258-262. 
Desrumaux, C. Risold, P.Y. Schroeder, H. Deckert, V. Masson, D. Athias, A. Laplanche, H. 
Le Guern, N. Blache, D. Jiang, X.C. Tall, A.R. Desor, D. Lagrost, L. (2005). 
Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content 
and increases anxiety in mice. FASEB, J19, 296-297. 
Ditzen, C. Jastorff, A.M. Keßler, M.S. Bunck, M. Teplytska, L. Erhardt, A. Krömer, S.A. 
Varadarajulu, J. Targosz, B.S. Sayan-Ayata, E.F. Holsboer, F. Landgraf, R. Turck, 
C.W. (2006).  Protein biomarkers in a mouse model of extremes in trait anxiety. Mol 
Cell Proteomics, 5, 1914-1920.  
do-Rego, J.C. Viana, A.F. Le Maître, E. Deniel, A. Rates Stela, M.K. Leroux-Nicollet, I. 
Costentin, J. (2006). Comparisons between anxiety tests for selection of anxious and 
non anxious mice. Behav Brain Res, 169(2), 282–288. 
Ferrari, P.F. Palanza, P. Parmigiani, S. Rodgers, R.J. (1998). Interindividual variability in 
Swiss male mice: relationship between social factors, aggression, and anxiety. 
Physiol Behav, 63, 821-827. 
Halliwell, B. (2006). Oxidative stress and neurodegeneration: where are we now? JNC, 97, 
1634-1658.  
Hovatta, I. Juhila, J. Donner, J. (2010). Oxidative stress in anxiety and comorbid disorders. 
Neurosci Res, 68(4), 261-275. 
Hovatta, I. Tennant, R.S. Helton, R. Marr, R.A. Singer, O. Redwine, J.M. Ellison, J.A. Schadt, 
E.E. Verma, I.M. Lockhart. D.J. Barlow, C. (2005). Glyoxalase 1 and glutathione 
reductase 1 regulate anxiety in mice. Nature, 438, 662-666. 
Krömer, S.A. Keßler, M.S. Milfay, D. Birg, I.N. Bunck, M. Czibere, L. Panhuysen, M. Pütz, B. 
Deussing, J.M. Holsboer, F. Landgraf, R. Turck, C.W. (2005). Identification of 
glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J 
Neurosci, 25, 4375-4384. 
www.intechopen.com
Relationship Between Oxidative Stress and Anxiety: Emerging 
Role of Antioxidants Within Therapeutic or Preventive Approaches 
 
37 
Kuloglu, M. Atmaca, M. Tezcan, E. Gecici, O. Tunckol, H. Ustundag, B. (2002a). Antioxidant 
enzyme activities and malondialdehyde levels in patients with obsessive-
compulsive disorder. Neuropsychobiology, 46, 27-32. 
Kuloglu, M. Atmaca, M. Tezcan, E. Gecici, O. Ustundag, B. Bulut, S. (2002b). Antioxidant 
enzyme and malondialdehyde levels in patients with panic disorder. 
Neuropsychobiology, 46:186-189. 
Mariani, E. Polidori, M.C. Cherubini, A. Mecocci. P. (2005). Oxidative stress in brain aging, 
neurodegenerative and vascular diseases: An overview. Journal of Chromatography 
B, 827, 65–75 
Masood, A. Nadeem, A. Mustafa, S.J. O’Donnell, J.M. (2008). Reversal of oxidative stress-
induced anxiety by inhibition of phosphodiesterase-2 in mice. J Pharmacol Exp Ther, 
326(2), 369-379. 
Mathew, S.J. Price, R.B. Charney, D.S. (2008). Recent advances in the neurobiology of 
anxiety disorders: implications for novel therapeutics. Am J Med Genet C, 148, 89-98. 
Michel, T.M. Frangou, S. Thiemeyer, D. Camara, S. Jecel, J. Nara, K. Brunklaus, A. 
Zoechling, R. Riederer, P. (2007). Evidence for oxidative stress in the frontal cortex inpatients 
w ith recurrent depressive disorder—a postmortem study. Psychiatry Res, 151, 145-
150. 
Ng, F. Berk, M. Dean, O. Bush, A.I. (2008). Oxidative stress in psychiatric disorders: 
evidence base and therapeutic implications. IJNP, 11 (6), 851-876.  
Oja, S.S. Janaky, R. Varga, V. Saransaari, P. (2000). Modulation of glutamate receptor 
functions by glutathione. NCI, 37, 299-306.  
Pandey, K.B. Rizvi, S.I. (2010). Markers of oxidative stress in erythrocytes and plasma 
during aging in humans. Oxid Med Cell Longev, 3, (1), 2-12. 
Pirkola, S.P. Isometsa, E. Suvisaari, J. Aro, H. Joukamaa, M. Poikolainen, K. Koskinen, S. 
Aromaa, A. Lonnqvist, J.K. (2005). DSM-IV mood-, anxiety- and alcohol use 
disorders and their comorbidity in the Finnish general population– results from the 
Health 2000 Study. Soc Psychiatry Psychiatr Epidemiol, 40, 1–10. 
Pitozzi V, Jacomelli M, Zaid M, Luceri C, Bigagli E, Lodovici M, Ghelardini C, Vivoli, E. 
Norcini, M. Gianfriddo, M. Esposto, S. Servili, M. Morozzi, G. Baldi, E. Bucherelli, 
C. Dolara, P. Giovannelli, L. (2010). Effects of dietary extra-virgin olive oil on 
behaviour and brain biochemical parameters in ageing rats. Br J Nutr, 1-10. 
Rammal, H. Bouayed, J. Falla, J. Boujedaini, N. Soulimani, R. (2010a). The Impact of high 
anxiety level on cellular and humoral immunity in mice. Neuroimmunomodulation, 
17, 1–8. 
Rammal, H. Bouayed, J. Soulimani, R. (2010b). A direct relationship between aggressive 
behavior in the resident/intruder test and cell oxidative status in adult male mice. 
Eur J Pharmacol, 627, 173–176. 
Rammal, H. Bouayed, J. Younos, C. Soulimani, R. (2008a). The impact of high anxiety level 
on the oxidative status of mouse peripheral blood lymphocytes, granulocytes and 
monocytes. Eur J Pharmacol, 589(1-3), 173-175. 
Rammal, H. Bouayed, J. Younos, C. Soulimani, R. (2008b). Evidence that oxidative stress is 
linked to anxiety-related behaviour in mice. Brain Behav Immun, 22(8), 1156-1159. 
Réus, G.Z. Stringari, R.B. de Souza, B. Petronilho, F. Dal-Pizzol, F. Hallak, J.E. Zuardi, A.W. 
Crippa, J.A. Quevedo, J. (2010). Harmine and imipramine promote antioxidant 
activities in prefrontal cortex and hippocampus. Oxid Med Cell Longev, 3(5) 325-331.  
www.intechopen.com
 
Anxiety Disorders 
 
38
Salim, S. Sarraj, N. Taneja, M. Saha, K. Tejada-Simon, M.V. Chugh, G. (2010). Moderate 
treadmill exercise prevents oxidative stress-induced anxiety-like behavior in rats. 
Behav Brain Res, 208, 545-552. 
Souza, C.G. Moreira, J.D. Siqueira, I.R. Pereira, A.G. Rieger, D.K. Souza, D. O. Souza, T.M. 
Portela, L.V. Perry, M.L.S. (2007).  Highly palatable diet consumption increases 
protein oxidation in rat frontal cortex and anxiety-like behavior. Life Sciences. 
81:198-203. 
Thornalley, P.J. (1996a). Pharmacology of methylglyoxal: formation, modification of proteins 
and nucleic acids, and enzymatic detoxification–a role in pathogenesis and 
antiproliferative chemotherapy. Gen Pharmacol, 27, 565-573. 
Thornalley, P.J. (1996b). The glyoxalase system: new developments towards functional 
characterization of a metabolic pathway fundamental to biological life. Biochem J, 
269, 1-11. 
Thornalley, P.J. (2006). Unease on the role of glyoxalase 1 in high-anxiety-related behaviour. 
Trends Mol Med, 12, 195-199. 
Valko, M. Leibfritz, D. Moncol, J. Cronin, M.T.D. Mazur, M. Telser, J. (2007). Free radicals 
and antioxidants in normal physiological functions and human disease. Int J 
Biochem Cell B, 39, 44-84. 
Viggiano, A. Monda, M. Turco, I. Incarnato, L. Vinno, V. Viggiano, E. Baccari, M. E. De 
Luca, B. (2006). Annurca apple-rich diet restores long-term potentiation and 
induces behavioral modifications in aged rats. Exp Neurol, 199(2), 354-361. 
Yasunari, K. Matsui, T. Maeda, K. Nakamura, M. Watanabe, T. Kiriike, N. (2006). Anxiety-
induced plasma norepinephrine augmentation increases reactive oxygen species 
formation by monocytes in essential hypertension. AJH, 19, 573-578.  
www.intechopen.com
Anxiety Disorders
Edited by Prof. Vladimir Kalinin
ISBN 978-953-307-592-1
Hard cover, 324 pages
Publisher InTech
Published online 01, August, 2011
Published in print edition August, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
During the last 2-3 decades drastic research progress in anxiety issues has been achieved. It concerns mostly
the study of different subtypes of anxiety and their treatment. Nevertheless, the data on anxiety pathogenesis
is less elaborated, although here a multidimensional approach exists. It includes neurochemistry,
pathophysiology, endocrinology and psychopharmacology. Again, we are able to recognize the multifarious
sense of anxiety, and the present collective monograph composed of 16 separate chapters depicting the
different aspects of anxiety. Moreover, a great part of book includes chapters on neurochemistry, physiology
and pharmacology of anxiety. The novel data on psychopathology and clinical signs of anxiety and its
relationship with other psychopathological phenomena is also presented. The current monograph may
represent an interest and be of practical use not only for clinicians but for a broad range of specialists,
including biochemists, physiologists, pharmacologists and specialists in veterinary.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Jaouad Bouayed (2011). Relationship Between Oxidative Stress and Anxiety: Emerging Role of Antioxidants
Within Therapeutic or Preventive Approaches, Anxiety Disorders, Prof. Vladimir Kalinin (Ed.), ISBN: 978-953-
307-592-1, InTech, Available from: http://www.intechopen.com/books/anxiety-disorders/relationship-between-
oxidative-stress-and-anxiety-emerging-role-of-antioxidants-within-therapeutic-1
© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed
under the terms of the Creative Commons Attribution-NonCommercial-
ShareAlike-3.0 License, which permits use, distribution and reproduction for
non-commercial purposes, provided the original is properly cited and
derivative works building on this content are distributed under the same
license.
